RSV-F-PRÄFUSIONSANTIGENE

Patent europeic · EP2707385 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2707385
Numer da la dumonda
EP12722057
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-05-2012
Publitgà
19-03-2014
Concedì
20-09-2017
La protecziun finescha il pli tard
13-05-2032
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C07K 14/135 (2006.01)
Prioritad
US 201161486005 P 13.05.2011
Dumonda PCT
PCT/US2012/037773 14.05.2012
Publicaziun PCT
WO2012/158613 22.11.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  3. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  4. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  5. 20-10-2017

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 20.10.2017

  6. 20-09-2017

    Concedì

    Published in Swissreg on 20.09.2017

Partidas

Possessur

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

SWANSON, Kurt

Emeryville, CA 94662-8097, US

CARFI, Andrea

Emeryville, CA 94662-8097, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.